| Literature DB >> 32355889 |
Mohammad Bilal1, Malorie Simons2, Asad Ur Rahman3, Zachary L Smith4, Shifa Umar5, Jonah Cohen1, Mandeep S Sawhney1, Tyler M Berzin1, Douglas K Pleskow1.
Abstract
Background and study aims There is a consensus among gastroenterology organizations that elective endoscopic procedures should be deferred during the COVID-19 pandemic. While the decision to perform urgent procedures and to defer entirely elective procedures is mostly evident, there is a wide "middle ground" of time-sensitive but not technically urgent or emergent endoscopic interventions. We aimed to survey gastroenterologists worldwide using Twitter to help elucidate these definitions using commonly encountered clinical scenarios during the COVID-19 pandemic. Methods A 16-question survey was designed by the authors to include common clinical scenarios that do not have clear guidelines regarding the timing or urgency of endoscopic evaluation. This survey was posted on Twitter. The survey remained open to polling for 48 hours. During this time, multiple gastroenterologists and fellows with prominent social media presence were tagged to disseminate the survey. Results The initial tweet had 38,795 impressions with a total of 2855 engagements. There was significant variation in responses from gastroenterologists regarding timing of endoscopy in these semi-urgent scenarios. There were only three of 16 scenarios for which more than 70 % of gastroenterologists agreed on procedure-timing . For example, significant variation was noted in regard to timing of upper endoscopy in patients with melena, with 44.5 % of respondents believing that everyone with melena should undergo endoscopic evaluation at this time. Similarly, about 35 % of respondents thought that endoscopic retrograde cholangiopancreatography should only be performed in patients with choledocholithiasis with abdominal pain or jaundice. Conclusion Our analysis shows that there is currently lack of consensus among gastroenterologists in regards to timing of semi-urgent or non-life-threatening procedures during the COVID-19 pandemic. These results support the need for the ongoing development of societal guidance for these "semi-urgent" scenarios to help gastroenterologists in making difficult triage decisions.Entities:
Year: 2020 PMID: 32355889 PMCID: PMC7165009 DOI: 10.1055/a-1153-9014
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Results of survey regarding timing of endoscopic procedures during COVID-19 pandemic.
| Indication | Most common decision | Percentage of highest votes, % (n) |
| Gastrointestinal bleeding | ||
Evaluation of melena | Everyone should have endoscopy | 44.5 (438) |
Evaluation of hematochezia | Scope patients with hemodynamic instability | 61.9 (389) |
Evaluation of upper gastrointestinal bleeding in cirrhosis | Everyone should have EGD | 87.6 (410) |
Procedures for common gastrointestinal signs and symptoms | EGD for acute onset of dysphagia | 55.8 (407) |
| Evaluation of dysphagia | ||
Evaluation of iron deficiency anemia | Defer endoscopic evaluation for now | 58.3 (48) |
Evaluation of abnormal weight loss | Defer endoscopic evaluation for now | 84.7 (359) |
| Concerns for dysplasia/cancer | ||
Colonoscopy for positive FIT/Fecal-FIT DNA (Cologuard) testing | Defer procedure for now | 70 (834) |
Ulcerative colitis with dysplasia | Defer chromoendoscopy for now | 52.6 (19) |
EMR for colon polyps | Defer colonoscopy for now | 63.3 (355) |
ESD of early gastric cancer | Defer EGD for now | 58.5 (340) |
Endoscopic therapy of dysplastic Barrett's esophagus | Defer EGD for now | 50.4 (421) |
Evaluation of double duct sign with EUS | Defer EUS for now | 53.5 (368) |
Evaluation of ampullary adenoma | Defer endoscopic resection for now | 53.5 (383) |
| Benign [pancreatobiliary indications] | ||
Evaluation of choledocholithiasis | ERCP only if abdominal pain/jaundice | 35.7 (338) |
Elective exchange of biliary stenting | Defer ERCP for now | 44.1 (59) |
Elective removal of pancreatic stent | Defer EGD/ERCP for now | 66 (50) |
EGD, esophagogastroduodenoscopy; FIT, fecal immunochemistry testing; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection; EUS, endoscopic ultrasound; ERCP, endoscopic retrograde cholangiopancreatography
Fig. 1 Demonstration of variation in gastroenterologists regarding timing of procedures for semi-urgent procedural indications.